Physician profile
V Christopher Inzerillo
NPI 1578546735
$5,975.44
in general payments reported to CMS, 2019-2025
18 companies · $228 in 2025
The $228 reported for 2025 was less than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,530 · 2020: $60.14 · 2021: $1,972 · 2022: $1,684 · 2023: $298 · 2024: $203 · 2025: $228.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $729.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $729.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Seapearl East, INC | $2,075.55 | 2021-2025 | |
| Stryker Corporation | $1,247.62 | 2019-2025 | Pangea |
| Arthrex, INC. | $1,240.05 | 2022 | |
| Joint Restoration Foundation, INC. | $289.48 | 2019 | |
| Depuy Synthes Sales INC. | $232.18 | 2020-2024 | Fms, Vapr, Healix Knotless Peek |
| Smith+Nephew, INC. | $223.16 | 2019-2024 | Stravix, Grafix Pl, Stravix Pl |
| Anika Therapeutics, INC. | $157.31 | 2021 | |
| Skeletal Dynamics INC | $128.00 | 2021 | |
| Trice Medical, INC. | $78.34 | 2021 | |
| Maxx Health INC | $63.28 | 2022 | |
| Zimmer Biomet Holdings, INC. | $58.93 | 2019-2020 | |
| Ferring Pharmaceuticals INC. | $57.21 | 2019-2025 | Euflexxa |
| Terumo Bct, INC. | $54.10 | 2019 | |
| Trilliant Surgical LLC. | $18.20 | 2023 | Tiger Large Cannulated Instrument Module, Arsenal Ankle 10 Hole 1/3 Tubular Plate |
| Pacira Pharmaceuticals Incorporated | $15.00 | 2024 | Exparel, Zilretta, Iovera |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $14.70 | 2019 | |
| Axogen | $11.30 | 2020 | |
| Cumberland Pharmaceuticals, INC. | $11.03 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw V Christopher Inzerillo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.